Clinical Trial Update: The Post-Marketing Safety and Immunogenicity Research of Speeda® Rabies Vaccine for Human Use [Phase 4]

View source ↗

Summary

Phase 4 post-marketing study on Speeda Rabies Vaccine completed, evaluating safety and immunogenicity in humans.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rabies

Drugs mentioned

• Speeda Rabies Vaccine (rabies vaccine)

Snippet

Sponsor: Beijing Center for Disease Control and Prevention | Conditions: Rabies Vaccine Allergy, Vaccination Adverse Event | Phase 4 | Status: COMPLETED